Adenoid Cystic Carcinoma Clinical Trials

58 clinical trials for Adenoid Cystic Carcinoma across international registries, including 17 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma — RECRUITING · PHASE2
• A Study of Becotatug Vedotin (MRG003) Combined With Epirubicin as Neoadjuvant Therapy for EGFR-Positive, Unresectable Recurrent Sinonasal Adenoid Cystic Carcinoma — RECRUITING · PHASE2
• A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors — RECRUITING · PHASE1
• CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC — RECRUITING · PHASE1
• Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma — RECRUITING · PHASE1
• Surgery Plus Postoperative Radiotherapy for T4 Sinonasal Adenoid Cystic Carcinoma: A Prospective Observational Study — RECRUITING
• Epirubicin Interventional Chemotherapy for Sinonasal Adenoid Cystic Carcinoma (SNACC): A Prospective Study — RECRUITING · PHASE2
• Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I) — RECRUITING · PHASE2
• Agnostic Therapy in Rare Solid Tumors — RECRUITING · PHASE2
• VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma — RECRUITING · PHASE1
• Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC) — RECRUITING · PHASE1
• Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial — RECRUITING · NA
• A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit — RECRUITING · PHASE1
• A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers — RECRUITING · PHASE2
• Clinical Trial of HG146 Administered to Participants with Adenoid Cystic Carcinoma — RECRUITING · PHASE2
• A PHASE 1A/1B, FIRST-IN-HUMAN, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RGT-61159 FOR TREATMENT OF PATIENTS WITH RELAPSED/REFRACTORY ADENOID CYSTIC CARCINOMA (ACC) OR COLORECTAL CARCINOMA (CRC) — RECRUITING · PHASE1
• Adenoid Cystic Carcinoma and Carbon Ion Only Irradiation — RECRUITING · PHASE2
• Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer — NOT_YET_RECRUITING · PHASE1
• A Phase 1, multicenter, open-label study of REM-422, a MYB mRNA degrader, in patients with recurrent or metastatic, adenoid cystic carcinoma. — TERMINATED · PHASE1
• 9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• A Study to Evaluate the Efficacy and Safety of Rivoceranib in Participants With Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC) — TERMINATED · PHASE2
• AL101 Before Surgery for the Treatment of Notch Activated Adenoid Cystic Cancer — COMPLETED · PHASE1
• Nivolumab and Ipilimumab in Treating Patients With Rare Tumors — ACTIVE_NOT_RECRUITING · PHASE2
• MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Testing Lenvatinib in Patients With Adenoid Cystic Carcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• Neoadjuvant Anlotinib and Epirubicin for T4 Sinonasal Adenoid Cystic Carcinoma — NOT_YET_RECRUITING · PHASE2
• SPARE-1st: Surgery Alone vs Surgery Plus Postoperative Radiotherapy for Sinonasal Adenoid Cystic Carcinoma — NOT_YET_RECRUITING
• 177Lu-PSMA (177Lu-PNT2002) in PSMA-Positive Adenoid Cystic Carcinoma — TERMINATED · PHASE2
• A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors — TERMINATED · PHASE1
• Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers — ACTIVE_NOT_RECRUITING · PHASE2
• Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma — COMPLETED · PHASE2
• Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC — ACTIVE_NOT_RECRUITING · PHASE1
• P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) — TERMINATED · PHASE1
• The Evaluation of the Effectiveness, Safety and Tolerability of Treatment, Using a PSMA-Lu177, in Patients with ACC- an Open, Non-commercial Clinical Trial — WITHDRAWN · PHASE2
• Surgical Strategy for Head and Neck Adenoid Cystic Cancer — COMPLETED
• A Study Of AL101In Patients With Adenoid Cystic Carcinoma (ACC) Bearing Activating Notch Mutations — COMPLETED · PHASE2
• Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies — TERMINATED · PHASE1
• Understanding the Burden of ACC Through the Eyes of Patients — COMPLETED
• Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy — OTHER · NA
• Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer Patients — COMPLETED · PHASE2
• A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies — COMPLETED · PHASE1
• MYPHISMO: MYB and PD-1 Immunotherapies Against Multiple Oncologies Trial — COMPLETED · PHASE1
• A Trial of All-trans Retinoic Acid (ATRA) in Advanced Adenoid Cystic Carcinoma — COMPLETED · PHASE2
• Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma — COMPLETED · PHASE2
• 9-ING-41 Plus Carboplatin in Patients With Advanced, Metastatic Salivary Gland Carcinoma — WITHDRAWN · PHASE2
• Diagnosis of Adenoid Cystic Carcinoma on 68Ga-PSMA-617 PET-CT and Therapy With 177Lu-EB-PSMA-617 — OTHER · PHASE1
• Study of Dovitinib (TKI258) in Adenoid Cystic Carcinoma — COMPLETED · PHASE2
• Trail Evaluating Particle Therapy With or Without Apatinib for H&N Adenoid Cystic Carcinoma — OTHER · PHASE2
• A PHASE 2, OPEN-LABEL, MULTI-CENTER STUDY OF AL101 (BMS-906024) IN PATIENTS WITH ADENOID CYSTIC CARCINOMA (ACC) BEARING ACTIVATING NOTCH MUTATIONS — COMPLETED · PHASE2
• A Study of Apatinib in Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck — OTHER · PHASE2

Refine this search